• Corpus ID: 4538888

Review: Cancer Morphogenesis: Role of Mitochondrial Failure

  title={Review: Cancer Morphogenesis: Role of Mitochondrial Failure},
  author={E. Fosslien},
Adenosine triphosphate (ATP) required for normal cell metabolism is mainly supplied by mitochondrial oxidative phosphorylation (OXPHOS), which is limited by available oxygen and modulated by cell signaling pathways. Primary or secondary OXPHOS failure shifts cell metabolism towards ATP generation by glycolysis (Warburg effect). The objective of this paper is to clarify the role of mitochondrial dysfunction in cancer morphogenesis and to elucidate how faulty morphogen gradient signaling and… 

Figures from this paper


Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth
The view that an increase in oxidative metabolism induced by mitochondrial frataxin may inhibit cancer growth in mammals is supported.
p53 Regulates Mitochondrial Respiration
It is shown that p53, one of the most frequently mutated genes in cancers, modulates the balance between the utilization of respiratory and glycolytic pathways, and Synthesis of Cytochrome c Oxidase 2 (SCO2) is identified as the downstream mediator of this effect.
ANT2 Isoform Required for Cancer Cell Glycolysis
A new model for ATP uptake in cancer cells is proposed implicating the {ANT2} isoform, in conjunction with hexokinase II and the β subunit of mitochondrial ATP synthase, in the Δψ maintenance and in the aggressiveness of cancer cells.
Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis*
Findings support a novel role for pyruvate in metabolic signaling and suggest a mechanism by which high rates of aerobic glycolysis can promote the malignant transformation and survival of cancer cells.
GRIM-19, a Cell Death Regulatory Protein, Is Essential for Assembly and Function of Mitochondrial Complex I
It is demonstrated that GRIM-19, a gene product with a specific role in IFN-RA-induced cell death, is a functional component of mitochondrial complex I and is essential for early embryonic development.
Altered metabolism and mitochondrial genome in prostate cancer
The metabolism of human prostate peripheral zone glandular epithelial cells is unique and malignant transformation of the prostate is associated with an early metabolic switch, leading to decreased zinc accumulation and increased citrate oxidation.
'The metabolism of tumours': 70 years later.
As a result of genetic alterations and intratumoral hypoxia, Hif-1alpha is overexpressed in the majority of common human cancers relative to the surrounding normal tissue and in human breast cancer and brain tumours, HIF-1 alpha overexpression is strongly correlated with tumour grade and vascularity.
Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas.
It is shown that the in vivo tumor glucose uptake of lung carcinomas, as assessed by positron emission tomography in 110 patients using 2-deoxy-2-[18F]fluoro-d-glucose as probe, inversely correlates with the bioenergetic signature determined by immunohistochemical analysis in tumor surgical specimens.
Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria
Different expression differences between mitochondria of normal and breast-infiltrating ductal carcinoma (IDC) cells are reported, possibly providing new cancer hallmarks.
A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis.
In CCRCs, pVHL deficiency is one of the factors responsible for down-regulation of the biogenesis of OXPHOS complexes, and the presence of wild-type VHL protein increased mitochondrial DNA and respiratory chain protein contents and permitted the cells to rely on their mitochondrial ATP production to grow in the absence of glucose.